Serum EGFR and serum HER‐2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy
暂无分享,去创建一个
P. Maisonneuve | M. Colleoni | A. Rocca | L. Zorzino | M. Sandri | G. Peruzzotti | M. Salvatici | H. Johansson | R. Passerini